LINC00632 and hepatocellular carcinoma: Moreover, CDR1as enhances the proliferative capacity and invasiveness of HCC cells by acting as a sponge of miR‐7 which inhibits signaling through the PIK3CD/phospho‐p70 S6 kinase (p70S6K)/the mTOR(mammalian target of rapamycin) pathway.